| Identification | Back Directory | [Name]
[2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amine | [CAS]
761440-75-9 | [Synonyms]
WDQZQPCYVLHWRA
2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidyl]aniline
2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)anilin
2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]aniline
2-Methoxy-4-(4-(4-Methylpiperazin-1-yl)piperidin-1-yl)benzenaMine
2-Methoxy-4-[4-(4-Methyl-1-piperazinyl)-1-piperidinyl]-BenzenaMine
[2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amine
Benzenamine, 2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]-
2-methoxy-4- [4- (4-methyl-1-piperazinyl) -1-piperazinyl] - aniline hydrochloride
[2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amine ISO 9001：2015 REACH | [EINECS(EC#)]
1592732-453-0 | [Molecular Formula]
C17H28N4O | [MDL Number]
MFCD12827955 | [MOL File]
761440-75-9.mol | [Molecular Weight]
304.435 |
| Chemical Properties | Back Directory | [Boiling point ]
479.3±45.0 °C(Predicted) | [density ]
1.126±0.06 g/cm3(Predicted) | [storage temp. ]
Keep in dark place,Inert atmosphere,2-8°C | [pka]
8.14±0.42(Predicted) | [InChI]
InChI=1S/C17H28N4O/c1-19-9-11-21(12-10-19)14-5-7-20(8-6-14)15-3-4-16(18)17(13-15)22-2/h3-4,13-14H,5-12,18H2,1-2H3 | [InChIKey]
WDQZQPCYVLHWRA-UHFFFAOYSA-N | [SMILES]
C1(N)=CC=C(N2CCC(N3CCN(C)CC3)CC2)C=C1OC |
| Hazard Information | Back Directory | [Uses]
[2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amine is an intermediate of Brigatinib which is a medicine used to treat cancer that suppresses epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK). |
|
|